Lanzkowsky's Manual of Pediatric Hematology and Oncology. Edition No. 6

  • ID: 3515790
  • Book
  • 788 Pages
  • Elsevier Science and Technology
1 of 4
Lanzkowsky's Manual of Pediatric Hematology and Oncology, Sixth Edition, is a comprehensive book on patient management, replete with algorithms and flow diagrams on diagnosis and management. Reflecting the considerable advances in the treatment and management of hematologic and oncologic diseases in children, the sixth edition of this successful clinical manual has been entirely updated to incorporate all current treatment protocols, new drugs, and management approaches. Its concise and easy-to-read format will enable readers to make accurate diagnoses and permit them to treat patients without having to reference larger medical textbooks.

Based on the new standards of genetic classification and prognostic information that have arisen in the past five years, the sixth edition includes two new chapters (Diagnostic, Molecular, and Genomic Methodologies for the Hematologist, Transfusion Medicine) and several new expanded chapters that were previously sections in consolidated chapters (Myelodysplasia, Myeloid Leukemias, Lymphoid Leukemias, Hemolytic Anemia, and Disorders of Coagulation).

- Presents a concise, systematic approach to all pediatric hematologic and oncologic disorders in one manual- Offers an alternative to bigger references which only cover either oncologic or hematologic disorders in twice as many pages- Presents an easy-to-read format: multiple tables, charts, and flow-diagrams for diagnosis and management of pediatric hematologic and oncologic disorders- Includes 2 new chapters and several expanded chapters: Diagnostic, Molecular and Genomic Methodologies for the Hematologist, Transfusion Medicine, Myelodysplasia, Myeloid Leukemias, and Lymphoid Leukemias

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Diagnostic, Molecular and Genomic Methodologies for the Hematologist / Oncologist
Vijay G. Sankaran
2. Hematologic Manifestations of Systemic Illness
Lawrence C. Wolfe
3. Classification and Diagnosis of Anemia in Children
Lanzkowsky Philip
4. Lymphadenopathy and Splenomegaly
Lanzkowsky Philip
5. Anemia During the Neonatal Period
Lanzkowsky Philip
6. Iron-Deficiency Anemia
Lanzkowsky Philip
7. Megaloblastic Anemia
Lanzkowsky Philip
8. Bone Marrow Failure
Jeffrey M. Lipton and Adrianna Vlachos
9. Hemolytic Anemia
Lawrence C. Wolfe
10. Red Cell Membrane and Enzyme Defects
Lionel Blanc and Lawrence C. Wolfe
11. Hemoglobinopathies
Janet L. Kwiatkowski
12. Polycythemia
Josef T. Prchal and Tsewang Tashi
13. Disorders of White Blood Cells
Mary Ann Bonilla and Jill S. Menell
14. Disorders of Platelets
James B. Bussel
15. Disorders of Coagulation
Suchitra S. Acharya
16. Lymphoproliferative Disorders
David T. Teachey
17. Myelodysplasia
Charlotte Niemeyer and M. Tarek Elghetany
18. Lymphoid leukemias
William L. Carroll and Teena Bhatla
19. Myeloid leukemias
Arlene Sara Redner and Rachel Markowitz Kessel
20. Histiocytosis Syndromes
Robert J. Arceci
21. Hodgkin Lymphoma
Debra L. Friedman
22. Non-Hodgkin Lymphoma
Howard Weinstein and Mary S. Huang
23. Central Nervous System Malignancies
Mark P. Atlas
24. Neuroblastoma
Bagatell Rochelle and Julie R. Park
25. Renal Tumors
Jeffrey Dome
26. Rhabdomyosarcoma and Other Soft-Tissue Sarcomas
Carolyn Fein Levy and Leonard H. Wexler
27. Malignant Bone Tumors
Noah Federman
28. Retinoblastoma
Ann-Marie Leahey
29. Germ Cell Tumors
Thomas A. Olson
30. Hepatic Tumors
Thomas A. Olson
31. Hematopoietic Stem Cell Transplantation
Indira Sahdev and Hisham Abdel-Azim
32. Management of Oncological Emergencies
Susan R. Rheingold
33. Supportive Care of Patients with Cancer
James H. Feusner and Anurag K. Agrawal
34. Evaluation, Investigation and Management of Late Effects
Jonathan D. Fish
35. Psychosocial Aspects of Cancer for Children and Their Families
Meg Tippy
36. Transfusion Medicine
Naomi L. C. Luban
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Lanzkowsky, Philip

Dr. Philip Lanzkowsky was born in Cape Town on March 17, 1932 and graduated high school from the South African College and obtained his MB ChB degree from the University of Cape Town School of Medicine in 1954 and his Doctorate degree in 1959 for his thesis on Iron Deficiency Anemia In Children. He completed a pediatric residency at the Red Cross War Memorial Children's Hospital in Cape Town in 1960. After working in Pediatrics at the University of Edinburgh and at St Mary's Hospital of the University of London, Dr. Lanzkowsky did a pediatric Hematology-Oncology fellowship at Duke University School of Medicine and at the University of Utah.

In 1963 he was appointed Consultant Pediatrician and Pediatric Hematologist to the Red Cross War Memorial Children's Hospital at the University of Cape Town and introduced Pediatric Hematology and Oncology as a distinct discipline. In 1965 he was appointed Director of Pediatric Hematology and Associate Professor of Pediatrics at the New York Hospital-Cornell University School of Medicine.

In 1970 he was appointed Professor of Pediatrics and Chairman of Pediatrics at Long Island Jewish Medical Center and established a division of Pediatric Hematology-Oncology which he directed until 2000. He was the founder of the Schneider Children's Hospital, which he developed, planned, and was the hospital's Executive Director and Chief of Staff from its inception in 1983 until 2010.

Dr. Lanzkowsky has received numerous honors and awards and has lectured extensively at various institutions and medical schools in the United States and around the world. In addition to having been the author of five editions of the Manual of Pediatric Hematology and Oncology used by clinicians worldwide, he is the author of How It All Began: The History of a Children's Hospital and over 280 scientific papers, abstracts, monographs, and book chapters.

Dr. Lanzkowsky's medical writings have been prodigious. His seminal contributions to the medical literature have included the first description of the relationship of pica to iron-deficiency anemia (Arch. Dis Child., 1959), Effects of timing of clamping of umbilical cord on infant's hemoglobin level (Br. Med. J., 1960), Normal oral D-xylose test values in children (New Engl. J. Med., 1963), Normal coagulation factors in women in labor and in the newborn (Thromboses at Diath. Hemorr., 1966), Erythrocyte abnormalities induced by malnutrition (Br. J. Haemat., 1967), Radiologic features in iron deficiency anemia (Am. J. Dis. Child., 1968), Isolated defect of folic acid absorption associated with mental retardation (Blood, 1969; Am. J. Med, 1970), Disaccharidase levels in iron deficiency (J. Pediat., 1981) and Hexokinase "New Hyde Park” in a Chinese kindred (Am. J. Hematol., 1981).

Lipton, Jeffrey M.
Jeffrey M. Lipton, MD, PhD is the Chief of Hematology/Oncology and Stem Cell Transplantation at the Steven and Alexandra Cohen Children's Medical Center of New York and Center Head, Patient Oriented Research, The Feinstein Institute for Medical Research. He is Professor, Elmezzi Graduate School of Molecular Medicine, The Feinstein Institute for Medical Research and Professor of Pediatrics and Molecular Medicine at the Hofstra North Shore - LIJ School of Medicine. He holds a B.A. from Queens College, City University of New York, a Ph.D in Chemistry from Syracuse University and an M.D. degree, magna cum laude, from Saint Louis University Medical School. He did his Pediatric residency training at the Children's Hospital, Boston, MA and his Pediatric Hematology/Oncology fellowship training at the Children's Hospital and the Sidney Farber Cancer Institute (now DFCI) in Boston. Dr. Lipton is a Past-President of the American Society of Pediatric Hematology/Oncology (ASPHO). His main interest is bone marrow failure.
Fish, Jonathan D.
Jonathan D. Fish, MD is Assistant Professor of Pediatrics at the Hofstra Northwell School of Medicine. He is Director of the Survivors Facing Forward Program, a long-term follow-up program for survivors of childhood cancer, in the division of Pediatric Hematology/Oncology and Stem Cell Transplantation at the Steven and Alexandra Cohen Children's Medical Center of New York. He holds a B.A., with distinction, from the University of Western Ontario and received his M.D. degree, magna cum laude, from the Upstate Medical Center of the State University of New York. He did his Pediatric training at the the Schneider Children's Hospital, New Hyde Park, NY ( Presently known as the Steven and Alexandra Children's Medical Center of New York) and completed his Pediatric Hematology-Oncology fellowship training at the Children's Hospital of Philadelphia. Dr. Fish received the American Society of Pediatric Hematology-Oncology Young Investigator Award in 2008. His clinical and research interest is on the late effects of childhood cancer treatment and survivorship care.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll